These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10753830)

  • 1. Acute onset hemoglobinemia and/or hemoglobinuria and sequelae following Rh(o)(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients.
    Gaines AR
    Blood; 2000 Apr; 95(8):2523-9. PubMed ID: 10753830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rh(0)(D) immune globulin intravenous administration for immune thrombocytopenic purpura.
    Gaines AR
    Blood; 2005 Sep; 106(5):1532-7. PubMed ID: 15878975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute renal failure after intravenous anti-D immune globulin in an adult with immune thrombocytopenic purpura.
    Chun NS; Savani B; Seder RH; Taplin ME
    Am J Hematol; 2003 Dec; 74(4):276-9. PubMed ID: 14635210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of whether the acute hemolysis associated with Rh(o)(D) immune globulin intravenous (human) administration for treatment of immune thrombocytopenic purpura is consistent with the acute hemolytic transfusion reaction model.
    Gaines AR; Lee-Stroka H; Byrne K; Scott DE; Uhl L; Lazarus E; Stroncek DF
    Transfusion; 2009 Jun; 49(6):1050-8. PubMed ID: 19220820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-D immunoglobulin-induced prolonged intravascular hemolysis and neutropenia.
    Alioglu B; Avci Z; Ozyurek E; Ozbek N
    J Pediatr Hematol Oncol; 2007 Sep; 29(9):636-9. PubMed ID: 17805040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura.
    Blanchette V; Imbach P; Andrew M; Adams M; McMillan J; Wang E; Milner R; Ali K; Barnard D; Bernstein M
    Lancet; 1994 Sep; 344(8924):703-7. PubMed ID: 7915773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous anti-D immune globulin-induced intravascular hemolysis in Epstein-Barr virus-related thrombocytopenia.
    Levendoglu-Tugal O; Jayabose S
    J Pediatr Hematol Oncol; 2001 Oct; 23(7):460-3. PubMed ID: 11878583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of anti-D for immune thrombocytopenic purpura in children.
    Naithani R; Kumar R; Mahapatra M; Tyagi S; Mishra P
    Indian Pediatr; 2010 Jun; 47(6):517-9. PubMed ID: 20019392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary use of passive surveillance and Mini-Sentinel to better characterize hemolysis after immune globulin.
    Winiecki S; Baer B; Chege W; Jankosky C; Mintz P; Baker M; Woodworth T; Nguyen M
    Transfusion; 2015 Jul; 55 Suppl 2():S28-35. PubMed ID: 26174895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to avoid splenectomy?
    Cooper N; Woloski BM; Fodero EM; Novoa M; Leber M; Beer JH; Bussel JB
    Blood; 2002 Mar; 99(6):1922-7. PubMed ID: 11877261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous Rh immune globulin for treating immune thrombocytopenic purpura.
    Sandler SG
    Curr Opin Hematol; 2001 Nov; 8(6):417-20. PubMed ID: 11604585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal failure after anti-D globulin treatment of idiopathic thrombocytopenic purpura.
    Kees-Folts D; Abt AB; Domen RE; Freiberg AS
    Pediatr Nephrol; 2002 Feb; 17(2):91-6. PubMed ID: 11875670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous anti-D immunoglobulin in the management of immune thrombocytopenic purpura.
    Smith N
    Curr Opin Hematol; 1996 Nov; 3(6):498-503. PubMed ID: 9372124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of intravenous immune globulin and high dose anti-D immune globulin as initial therapy for childhood immune thrombocytopenic purpura.
    Kane I; Ragucci D; Shatat IF; Bussel J; Kalpatthi R
    Br J Haematol; 2010 Apr; 149(1):79-83. PubMed ID: 20096011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin.
    Tarantino MD; Madden RM; Fennewald DL; Patel CC; Bertolone SJ
    J Pediatr; 1999 Jan; 134(1):21-6. PubMed ID: 9880444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGIV-C, a novel intravenous immunoglobulin: evaluation of safety, efficacy, mechanisms of action, and impact on quality of life.
    Bussel JB; Eldor A; Kelton JG; Varon D; Brenner B; Gillis S; Angiolillo A; Kulkarni R; Abshire TC; Kelleher J;
    Thromb Haemost; 2004 Apr; 91(4):771-8. PubMed ID: 15045139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid irreversible encephalopathy associated with anti-D immune globulin treatment for idiopathic thrombocytopenic purpura.
    Christopher K; Horkan C; Barb IT; Arbelaez C; Hodgdon TA; Yodice PC
    Am J Hematol; 2004 Nov; 77(3):299-302. PubMed ID: 15495245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal insufficiency and failure associated with immune globulin intravenous therapy--United States, 1985-1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Jun; 48(24):518-21. PubMed ID: 10401909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. After eight-year-tolerance minimal i.v. anti-D infusions unleash hemolysis in a patient with immune thrombocytopenic purpura (ITP).
    Rewald MD; Francischetti MM
    Transfus Apher Sci; 2004 Apr; 30(2):105-10. PubMed ID: 15062747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal impairment, hemoglobinuria, and hemoglobinemia among patients with idiopathic thrombocytopenic purpura.
    Xue F; Wentworth C; Ganesh V; Gastanaga V; Stryker S; Cha S; Zhao S
    Am J Hematol; 2011 Sep; 86(9):738-42. PubMed ID: 21786287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.